Sreenath M. Krishnan

Author

Uppsala University ORCID

Also Known As

S Krishnan, S M Krishnan, S.M. Krishnan, SM Krishnan, Sreekumar Krishnan, Sreenath M. Krishnan

Publications

583

Citations

H-Index

Concepts

All Affiliations

Uppsala University Nanyang Technological University Roche (Switzerland)Roche (France)Genoscience Pharma (France)

About

Sreenath M. Krishnan is an author at Uppsala University specializing in medicine, engineering, and biomedical signal processing.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	62
2	Engineering	2	2	166
3	Health Sciences	1	1	20
4	Public Health	1	1	146
5	Allergy	1	1	31

Sreenath M. Krishnan

Publications

447

Citations

H-Index

Page 1

	Year	Citations
Organ Donation and Utilization in the United States: 1998–2007 Janet E. Tuttle‐Newhall, Sreenath M. Krishnan, Michel Lévy, American Journal of Transplantation	2009	160
Comprehensive analysis of cardiac health using heart rate signals U. Rajendra Acharya, N. Kannathal, Sreenath M. Krishnan Physiological Measurement Heart FailureEngineeringMeasurementHrv AnalysisWearable Technology	2004	146
CD19-CD28: an affinity-optimized CD28 agonist for combination with glofitamab (CD20-TCB) as off-the-shelf immunotherapy Johannes Sam, Thomas Höfer, Christine Kuettel, Blood ImmunologyImmunodominanceImmunologic MechanismImmunotherapeuticsCd4 T Cell Responses	2024	31
Multistate model for pharmacometric analyses of overall survival in HER2‐negative breast cancer patients treated with docetaxel Sreenath M. Krishnan, Lena E. Friberg, René Bruno, CPT Pharmacometrics & Systems Pharmacology	2021	22
Autoregressive modeling and classification of cardiac arrhythmias Narayanan Srinivasan, Dingfei Ge, Sreenath M. Krishnan Electrophysiological EvaluationHeart FailureVentricular FibrillationBiosignal ProcessingNeural Network	2002	20
Wavelet transform domain data embedding in a medical image Samarendra Dandapat, Jing Xu, O. Chutatape, EngineeringBiomedical Signal AnalysisImage AnalysisImage CompressionBiostatistics	2005	20
Tumor growth inhibition modeling of individual lesion dynamics and interorgan variability in HER2‐negative breast cancer patients treated with docetaxel Sreenath M. Krishnan, Sofiene S. Laarif, Brendan C. Bender, CPT Pharmacometrics & Systems Pharmacology	2021	14
Model-based Dose Individualization of Sunitinib in Gastrointestinal Stromal Tumors Maddalena Centanni, Sreenath M. Krishnan, Lena E. Friberg Clinical Cancer Research	2020	13
Multistate Pharmacometric Model to Define the Impact of Second‐Line Immunotherapies on the Survival Outcome of the <scp>IMpower131</scp> Study Sreenath M. Krishnan, Lena E. Friberg, François Mercier, Clinical Pharmacology & Therapeutics ImmunodeficienciesImmunologyMultistate Pharmacometric ModelPathologyImmunotherapeutics	2023	11
A dynamic nonlinear time domain model for reconstruction and compression of cardiovascular signals with application to telemedicine D. Narayana Dutt, Sreenath M. Krishnan, Narayanan Srinivasan Computers in Biology and Medicine	2002	10

Page 1